Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular.

Slides:



Advertisements
Similar presentations
Volume 16, Issue 12, Pages (December 2014)
Advertisements

Molecular Therapy - Nucleic Acids
A Novel Cinnamide YLT26 Induces Breast Cancer Cells Apoptosis via ROS-Mitochondrial Apoptotic Pathway in Vitro and Inhibits.
Repression of COUP-TFI Improves Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Insulin-Producing Cells  Tao Zhang, Xiao-Hang Li, Dian-Bao.
Molecular Therapy - Nucleic Acids
Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in.
Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a Cell Physiol Biochem.
MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.
Cell Physiol Biochem 2017;44:1867– DOI: /
Volume 15, Issue 6, Pages (June 2009)
Volume 145, Issue 2, Pages (August 2013)
Shinichi Sakamoto, Steven Schwarze, Natasha Kyprianou  European Urology 
Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP  Hui Wang, Kai Li, Yu Mei, Xuemei Huang, Zhenglin Li, Qingzhu.
Hydrogen Sulfide Demonstrates Promising Antitumor Efficacy in Gastric Carcinoma by Targeting MGAT5  Rui Wang, Qilin Fan, Junjie Zhang, Xunan Zhang, Yuqi.
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Cell Physiol Biochem 2016;39: DOI: /
Volume 18, Issue 2, Pages (August 2010)
Molecular Therapy - Nucleic Acids
RORα inhibits cell proliferation and expression of the E2F1-targeted genes. RORα inhibits cell proliferation and expression of the E2F1-targeted genes.
Volume 9, Issue 2, Pages (February 2011)
Uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non- Small-Cell Lung Cancer  Jun Zhou, Chenghai Wang, Weijuan Gong, Yandan.
Volume 53, Issue 5, Pages (March 2014)
Tyrosinase-Based Reporter Gene for Photoacoustic Imaging of MicroRNA-9 Regulated by DNA Methylation in Living Subjects  Haifeng Zheng, Lin Zhou, Yaru.
Volume 22, Issue 10, Pages (October 2014)
Molecular Therapy - Nucleic Acids
Volume 145, Issue 2, Pages (August 2013)
Volume 25, Issue 3, Pages (March 2017)
Wenqi Wang, Nan Li, Xu Li, My Kim Tran, Xin Han, Junjie Chen 
Volume 10, Issue 8, Pages (March 2015)
Volume 25, Issue 9, Pages (September 2017)
Molecular Therapy - Nucleic Acids
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 137, Issue 6, Pages (June 2009)
Volume 16, Issue 12, Pages (December 2008)
MiR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling  Hua Jin, Song Luo, Yun Wang, Chang Liu, Zhenghao.
Volume 23, Issue 1, Pages (January 2015)
BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells  Duc-Hiep Bach,
miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
Molecular Therapy - Nucleic Acids
Induced-Decay of Glycine Decarboxylase Transcripts as an Anticancer Therapeutic Strategy for Non-Small-Cell Lung Carcinoma  Jing Lin, Jia Hui Jane Lee,
Volume 13, Issue 1, Pages (January 2008)
Molecular Therapy - Nucleic Acids
Lu Zheng, Nan You, Xiaobing Huang, Huiying Gu, Ke Wu, Na Mi, Jing Li 
Molecular Therapy - Nucleic Acids
Marta Vilalta, Marjan Rafat, Amato J. Giaccia, Edward E. Graves 
Induced-Decay of Glycine Decarboxylase Transcripts as an Anticancer Therapeutic Strategy for Non-Small-Cell Lung Carcinoma  Jing Lin, Jia Hui Jane Lee,
Volume 19, Issue 8, Pages (August 2011)
Suppression of IGF1R in Melanoma Cells by an Adenovirus-Mediated One-Step Knockdown System  Haoran Xin, Mingxing Lei, Zhihui Zhang, Jie Li, Hao Zhang,
Figure 1. LOC is highly expressed in NPC and predicts unfavorable prognosis. (A) Differential gene expression ... Figure 1. LOC is highly expressed.
Volume 17, Issue 2, Pages (February 2009)
Volume 25, Issue 4, Pages (April 2017)
Volume 18, Issue 12, Pages (March 2017)
Repression of COUP-TFI Improves Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Insulin-Producing Cells  Tao Zhang, Xiao-Hang Li, Dian-Bao.
RNA Polymerase II Activity of Type 3 Pol III Promoters
Volume 13, Issue 7, Pages (November 2015)
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
MiR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1  Qi Song, Quanbo Ji, Jingbo Xiao, Fang Li, Lingxiong Wang, Yin.
Volume 26, Issue 1, Pages (January 2018)
Volume 5, Issue 6, Pages (December 2013)
The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2  Cheng-Cao Sun, Ling Zhang, Guang.
Molecular Therapy - Nucleic Acids
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
Volume 24, Issue 10, Pages (October 2016)
Paracrine Apoptotic Effect of p53 Mediated by Tumor Suppressor Par-4
Gemcitabine-Incorporated G-Quadruplex Aptamer for Targeted Drug Delivery into Pancreas Cancer  Jun Young Park, Ye Lim Cho, Ju Ri Chae, Sung Hwan Moon,
Volume 53, Issue 5, Pages (March 2014)
Volume 23, Issue 4, Pages (April 2015)
c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1
Presentation transcript:

Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular Therapy - Nucleic Acids  Volume 9, Pages 387-398 (December 2017) DOI: 10.1016/j.omtn.2017.10.016 Copyright © 2017 The Authors Terms and Conditions

Figure 1 Antiviral Activity of Shrimp miR-34 in Shrimp (A) The expression profile of shrimp miR-34 in WSSV-challenged shrimp. Shrimp were infected with WSSV. As a control, PBS was included in the injection. At different times post-infection, shrimp were subjected to northern blot analysis (NB) to evaluate the level of miR-34. The numbers represent the time points after WSSV infection in the time course assays. U6 was used as a control. The treatments are shown on the left and the probes are indicated on the right. (B) The detection of shrimp miR-34 expression in miR-34-silenced shrimp. Shrimp were co-injected with WSSV and AMO-miR-34. AMO-miR-34-scrambled was included in the injection as a control. At various times after injection, shrimp were collected for northern blot analysis (NB) to evaluate the level of miR-34. (C) The influence of shrimp miR-34 silencing on virus copy number. The WSSV copy number in virus-challenged and miR-34-silenced shrimp was quantified by real-time qPCR at different times post-infection. (D) The effects of shrimp miR-34 silencing on WSSV-infected shrimp mortality. The numbers on the horizontal axis indicate the post-infection days. (E) The overexpression of miR-34 in shrimp. Shrimp were simultaneously injected with WSSV and shrimp miR-34. As a control, miR-34-scrambled was included in the injection. At different times post-infection, shrimp hemolymph was subjected to northern blotting. U6 was used as a control. The numbers indicate the time points post-infection. The probes are shown on the right. (F) The detection of WSSV copy number in miR-34-overexpressing shrimp by real-time qPCR. (G) Shrimp mortality assays. The treatments are shown at the top. The numbers on the horizontal axis indicate the post-infection days. Statistically significant differences between treatments are indicated with asterisks (error bar, SD; *p < 0.05 and **p < 0.01). Molecular Therapy - Nucleic Acids 2017 9, 387-398DOI: (10.1016/j.omtn.2017.10.016) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Antitumor Activity of Shrimp miR-34 in Breast Cancer Cells (A) Sequence alignment of shrimp miR-34 and human miR-34a. (B) The expression of shrimp miR-34 in breast cancer cells. MDA-MB-231 or MDA-MB-435 cells were transfected with miR-34 or miR-34-scrambled. At 36 hr after transfection, the cells were subjected to northern blotting. U6 was used as a control. (C) Quantification of miR-34 in breast cancer cells. MDA-MB-231 or MDA-MB-435 cells were transfected with shrimp miR-34 or miR-34-scrambled. At 36 hr after transfection, the expression level of miR-34 in cells was analyzed by real-time qPCR. Negative control represents the cells without any treatment. (D) The effects of shrimp miR-34 on cancer cell proliferation. The proliferation rates of miR-34-transfected MDA-MB-231 and MDA-MB-435 cells were examined. MiR-34-scrambled and the cells without any treatment (negative control) were used as controls. (E) The influence of shrimp miR-34 on the cell cycle of breast cancer cells. MDA-MB-231 and MDA-MB-435 cells were transfected with the synthesized shrimp miR-34. As controls, the cells without any treatment (negative control) and the cells transfected with miR-34-scrambled were analyzed. At 36 hr after transfection, the cell cycle was examined by flow cytometry. (F) The impact of shrimp miR-34 on apoptosis of cancer cells. The cancer cells were transfected with shrimp miR-34 or miR-34-scrambled. Then 36 hr later, the percentage of apoptotic cancer cells was evaluated by flow cytometry. The cells without any treatment (negative control) were used as controls. (G) The influence of shrimp miR-34 expression on cancer cell metastasis. miR-34-transfected cancer cells were subjected to wound-healing assays to evaluate the migration ability of cancer cells. (H) The effects of shrimp miR-34 on breast cancer cell migration. MDA-MB-231 and MDA-MB-435 cells were transfected with synthesized miR-34 or miR-34-scrambled and further cultured for 36 hr. (I) The effects of shrimp miR-34 expression on breast cancer cell adhesion. As a control, miR-34-scrambled was included in the assay. (J) The role of shrimp miR-34 in breast cancer cell invasion. Scale bar, 100 μm. In all panels, statistically significant differences between treatments are represented with asterisks (error bar, SD; *p < 0.05 and **p < 0.01). Molecular Therapy - Nucleic Acids 2017 9, 387-398DOI: (10.1016/j.omtn.2017.10.016) Copyright © 2017 The Authors Terms and Conditions

Figure 3 The Mechanism of Shrimp miR-34 in Inhibiting Breast Cancer Progression (A) The prediction of genes targeted by shrimp miR-34. The seed sequence of miR-34 is underlined. (B) The direct interaction between shrimp miR-34 and its target genes (i.e., CCND1, CDK6, CCNE2, E2F3, MET, or FOSL1) in breast cancer cells (MDA-MB-231). Luciferase activity was normalized to the ratio of firefly and Renilla luciferase activities. (C) The effects of shrimp miR-34 expression on the expression of miR-34 target genes in breast cancer cells (MDA-MB-231 and MDA-MB-435). (D) The influence of shrimp miR-34 expression on the expression of miR-34 target gene-encoding proteins in breast cancer cells. Protein levels were detected using western blot analysis. As a control, miR-34-scrambled was included in the transfection. Tubulin was used as a loading control. (E) The loading of shrimp miR-34 onto the human Ago2 complex. Shrimp miR-34 was incubated with the human Ago2 complex, followed by EMSA. Shrimp miR-34 was visualized by ethidium bromide staining (top). Human Ago2 protein was detected with western blot analysis (bottom). The wedge indicates the concentration gradient of human Ago2 complex. (F) A model for the role of miR-34-mediated cancer cell growth and metastasis. In all panels, statistically significant differences between treatments are represented with asterisks (error bar, SD; *p < 0.05 and **p < 0.01). Molecular Therapy - Nucleic Acids 2017 9, 387-398DOI: (10.1016/j.omtn.2017.10.016) Copyright © 2017 The Authors Terms and Conditions

Figure 4 The Suppression of Breast Tumor Growth and Metastasis by Shrimp miR-34 In Vivo (A) A flow chart of the in vivo experiments. Tumor growth and metastasis were examined weekly. (B) Tumor growth curves in mice subjected to different treatments. (C) Sizes of the solid tumors in mice subjected to different treatments. Tumors were harvested 6 weeks after injection. (D) The expression level of miR-34 in the blood of mice. At 6 weeks after injection, the blood of mice subjected to different treatments was analyzed by real-time qPCR to evaluate miR-34 expression. (E) The detection of miR-34 expression in solid tumors of mice subjected to various treatments by real-time qPCR analysis. (F) The expression levels of miR-34 target genes in solid tumors. (G) The expression levels of miR-34 target gene-encoding proteins in solid tumors. Protein levels were detected by western blot analysis. Tubulin was used as a control. (H) Immunohistochemical analysis of miR-34 target gene-encoding proteins in solid tumors. The brown and blue colors represent the proteins and nuclei, respectively. The proteins for the detection are indicated on the left. Scale bar, 100 μm. (I) The loading of shrimp miR-34 onto human Ago2 complex in tumor cells derived from mice. Human Ago2 complex of tumor cells treated with shrimp mR-34 or physiological saline was immunoprecipitated, followed by western blot analysis (bottom). Shrimp miR-34 in human Ago2 complex was detected by real-time qPCR (top). (J) The metastasis of breast cancer cells in mice. The capacity of breast cancer cell metastasis in mice subjected to different treatments was examined weekly after injection. Images showing cancer cell metastasis to the lungs of mice at 4 weeks after injection are shown. (K) Representative images displaying lung tumor nodules in mice subjected to various treatments. (L) Detection of miR-34 expression level in the blood of mice subjected to different treatments using real-time qPCR. Statistically significant differences between treatments are indicated using asterisks (error bar, SD; *p < 0.05 and **p < 0.01). Molecular Therapy - Nucleic Acids 2017 9, 387-398DOI: (10.1016/j.omtn.2017.10.016) Copyright © 2017 The Authors Terms and Conditions